Document is current
Any future updates will be listed below
-
Authors
Xiong, Monica
Wang, Chao
Gratuze, Maud
Saadi, Fareeha
Bao, Xin
Bosch, Megan E.
Lee, Choonghee
Jiang, Hong
Serrano, Javier Remolina
Gonzales, Ernesto R.
Kipnis, Michal
Holtzman, David M. http://orcid.org/0000-0002-3400-0856
-
Funding
Funding for this research was provided by:
NIH (AG062027, RF1NS090934, RF1AG047644, R01 NS034467, P01 AG078106)
JPB Foundation
Cure Alzheimer's Fund
BrightFocus Foundation (A2018128F, A2020257F)
- License Information
-
More Information
Article History
Received: 1 September 2022
Accepted: 2 March 2023
First Online: 16 March 2023
Declarations
:
: Not applicable.
: Not applicable.
: M.X. is an employee of Genentech. D.M.H. is as an inventor on a patent licensed by Washington University to NextCure on the therapeutic use of anti-APOE antibodies. D.M.H. co-founded and is on the scientific advisory board of C2N Diagnostics. D.M.H. is on the scientific advisory board of Denali, Genentech, and Cajal Neuroscience and consults for Alector. All other authors declare that they have no competing interests to disclose.
